We are live on
!
Find out more
CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
–
AUM
$7.06B
AUM Growth
+$739M
(+12%)
Cap. Flow
+$195M
Cap. Flow
% of AUM
2.76%
Top 10 Holdings %
Top 10 Hldgs %
64.54%
Holding
1,102
New
171
Increased
503
Reduced
296
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$53M |
| 2 |
iShares Gold Trust
IAU
|
+$36.5M |
| 3 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$25.8M |
| 4 |
Palantir
PLTR
|
+$25.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Innovation ETF
ARKK
|
+$68.1M |
| 2 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$20.3M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$17M |
| 4 |
Invesco Preferred ETF
PGX
|
+$15.5M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.17% |
| 2 | Consumer Discretionary | 6.79% |
| 3 | Healthcare | 3.61% |
| 4 | Financials | 3.09% |
| 5 | Communication Services | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Linde
LIN
$226B
| $3.14M | 0.04% |
10,854
+2,619
| +32% | +$764K |
|
152
CRISPR Therapeutics
CRSP
$5.01B
| $3.1M | 0.04% |
19,116
+1,513
| +9% | +$184K |
|
153
WisdomTree US LargeCap Dividend Fund
DLN
$6.37B
| $3.02M | 0.04% |
50,208
-1,522
| -3% | -$90.7K |
|
154
Altria Group
MO
$113B
| $2.99M | 0.04% |
61,601
-7,759
| -11% | -$381K |
|
155
Mondelez International
MDLZ
$80.2B
| $2.93M | 0.04% |
46,655
+2,888
| +7% | +$178K |
|
156
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.39B
| $2.92M | 0.04% |
185,579
| – | – |
|
157
Baidu
BIDU
$36.9B
| $2.92M | 0.04% |
14,334
+3,591
| +33% | +$718K |
|
158
Broadcom
AVGO
$2.01T
| $2.9M | 0.04% |
60,890
+7,130
| +13% | +$330K |
|
159
Zillow
Z
$7.39B
| $2.88M | 0.04% |
23,585
+4,948
| +27% | +$602K |
|
160
Elevance Health
ELV
$84.7B
| $2.79M | 0.04% |
7,311
+6,103
| +505% | +$2.33M |
|
161
iShares S&P 500 Value ETF
IVE
$49.6B
| $2.78M | 0.04% |
18,840
-2,038
| -10% | -$300K |
|
162
Vanguard Morningstar Large-Cap ETF
VV
$54B
| $2.78M | 0.04% |
13,857
-5,205
| -27% | -$1.02M |
|
163
Morgan Stanley
MS
$339B
| $2.7M | 0.04% |
29,483
-2,736
| -8% | -$235K |
|
164
Emerson Electric
EMR
$87.2B
| $2.69M | 0.04% |
27,929
+6,731
| +32% | +$633K |
|
165
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $2.67M | 0.04% |
67,984
-9,161
| -12% | -$355K |
|
166
Schwab US Dividend Equity ETF
SCHD
$105B
| $2.66M | 0.04% |
105,597
+79,518
| +305% | +$2.01M |
|
167
Deere & Co
DE
$165B
| $2.65M | 0.04% |
7,484
+4,197
| +128% | +$1.53M |
|
168
FedEx
FDX
$74.8B
| $2.64M | 0.04% |
8,849
-1,165
| -12% | -$346K |
|
169
Coinbase
COIN
$38.6B
| $2.62M | 0.04% |
+10,351
| New | +$2.69M |
|
|
NVTA
170
DELISTED
Invitae Corporation
NVTA
| $2.6M | 0.04% |
77,119
+20,139
| +35% | +$655K |
|
171
Lockheed Martin
LMT
$134B
| $2.58M | 0.04% |
6,832
-310
| -4% | -$119K |
|
172
iShares Dow Jones US ETF
IYY
$3.04B
| $2.54M | 0.04% |
23,476
| – | – |
|
173
Citigroup
C
$226B
| $2.49M | 0.04% |
35,151
+21,142
| +151% | +$1.56M |
|
174
Twilio
TWLO
$29B
| $2.46M | 0.03% |
6,230
+1,814
| +41% | +$630K |
|
175
Unilever
UL
$137B
| $2.42M | 0.03% |
36,743
-740
| -2% | -$49.2K |
|
Similar funds
CHP
FAM
OAG
BA
Cresset Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Cresset Asset Management held 1,102 positions worth $7.06B, up 12% from $6.32B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Cresset Asset Management's Q2 2021 filing shows 171 new, 503 increased, 296 reduced and 86 closed positions. Its largest new stake was RTX Corp: 183,725 shares worth $15.7M. The largest sale was ARK Innovation ETF, an estimated $68.1M.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Cresset Asset Management's largest Q2 2021 buy was RTX Corp: 183,725 shares worth $15.7M.
- Cresset Asset Management added most to Apple in Q2 2021, an estimated $53M increase.
- Cresset Asset Management's biggest Q2 2021 reduction was ARK Innovation ETF, cutting an estimated $68.1M.
- Cresset Asset Management fully exited iShares MSCI USA Value Factor ETF in Q2 2021, selling an estimated $20.3M.
- Cresset Asset Management's ten largest holdings make up 65% of its $7.06B portfolio in Q2 2021.
- Cresset Asset Management opened 171 new positions and closed 86 in Q2 2021.
- Cresset Asset Management's portfolio value rose 12% quarter-over-quarter to $7.06B.
Based on Cresset Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.